SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 115 0 SEPR
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8205I would love to invest with those guys. Those secondary LBO/venture funds have Robohogs-4/11/2005
8204Yes, Zopiclone (Imovane) is the biggest-selling sleep drug in Europe. Here'Biomaven-4/11/2005
8203Sounds like an LBO. Is SNY (or is it someone else) selling Zopiclone in Europe?Robohogs-4/11/2005
8202The royalty deals are typically a license to steal money. IRR's of 25%. PetBiomaven-4/11/2005
8201With a 5% royalty rate that would mean, ignoring time value of money, they need Robohogs-4/11/2005
8200Guys and gals - Go read the latest update to the SNY news - issue relates to cRobohogs-4/11/2005
8199An outfit called Paul Royalty bought the royalty rights from Aventis for "uBiomaven-4/11/2005
8198From the pr, I thought this was significant, encouraging, and, I think, new: <quidditch-4/11/2005
8197I'm sure the scrip number is a bolus of pent up demand, esp considering how rkrw-4/11/2005
8196Sorry for the heavy posting rate here but a very heavy news day for Lunesta. EaRobohogs-4/11/2005
8195I had not realized that SEPR had grabbed those intl right from Sanofi, though. Robohogs-4/11/2005
8194In Europe, the benzodiazpines are accepted, along with the memory and abuse liabBiotech Jim-4/11/2005
8193Good news keep on coming. I particularly liked this from PR - "With the rRobohogs-4/11/2005
8192LUNESTA(TM) Second Six-Month Study Data Confirms Findings of First Six-Month StuIcebrg-4/11/2005
8191I have a couple of serious questions that others may have thoughts on. 1. If lRobohogs-4/11/2005
8190Wow!!! Ambien CR 2 cycle approval - must be arguing labelling and either 7-10 dRobohogs-4/11/2005
8189Very strange - PDUFA on Ambien was Friday and still no word. Even if the approvRobohogs-4/11/2005
8188Finding Lunesta Leaving Many Seniors Sleepless By Tucker Sutherland, editor ApIcebrg-4/11/2005
8187My pleasure - it allows my to synthesize my thoughts. JonRobohogs-4/8/2005
8186<Today> Then I guess we are in for a fun weekend. Thanks for the updateskenhott-4/8/2005
8185Today. JonRobohogs-4/8/2005
8184I thought the date for Ambien CR is Apr 23rd????? What am I missing?kenhott-4/8/2005
8183Just checked FDA site and the SNY sites - nothing yet. JonRobohogs-4/8/2005
8182As usual, FDA goes to the deadline with PDUFA. Guess we will hear SNY news tomoRobohogs-4/7/2005
8181LUNESTA(TM) Now Widely Available by Prescription to Treat Insomnia Thursday ApriA.J. Mullen-4/7/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News